ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Methylmalonic acid, vitamin B12, and mortality risk in patients with preexisting coronary heart disease: a prospective cohort study

Guo, Junchen; Liu, Xiaoxuan; Wang, Zeng; Lu, Rongzhe; Liu, Yige; Zhang, Yiying; Tian, Wei; Fang, Shaohong; Wang, Shanjie*; Yu, Bo*哈尔滨医科大学
Nutrition Journal2023-11-29DOI: 10.1186/s12937-023-00900-6
1被引5阅读
引用收藏
分享

摘要

Background The inconsistent relationship between Vitamin B12 (B12), methylmalonic acid (MMA, marker of B12 deficiency) and mortality was poorly understood, especially in patients with coronary heart disease (CHD). This study aims to investigate the association of serum MMA, and B12-related biomarkers (serum level, dietary intake, supplement use, and sensibility to B12) with all-cause and cardiovascular mortality in adults with CHD.Methods The data of this study were from a subcohort within the US National Health and Nutrition Examination Survey (NHANES). We included adults with preexisting CHD with serum MMA and B12, and dietary B12 intake measurements at recruitment. All participants were followed up until 31 December 2019. Weighted Cox proportional hazard regression was used to estimate hazard ratios (HR) and 95% CI of mortality risk.Results Overall, 1755 individuals (weighted mean [SE] age, 65.2 [0.5] years; 1047 men [weighted 58.5%]) with CHD were included, with geometric mean levels of serum MMA 182.4 nmol/L, serum B12 494.5 pg/ml, and dietary B12 intake 4.42 mg/day, and percentage of B12 supplements use 39.1%. During a median follow-up of 7.92 years, 980 patients died. Serum B12 concentration, dietary B12 intake and supplements use were not significantly associated with mortality risk (each p >= 0.388). In contrast, individuals in the top tertile of MMA had multivariable-adjusted HRs (95% CIs) of 1.70 (1.31-2.20) for all-cause mortality, and 2.00 (1.39-2.89) for cardiovascular mortality (both p trend < 0.001) compared to those in the bottom tertile of MMA. MMA-related mortality risk was particularly higher among participants with sufficient serum B12 (p < 0.001). CHD patients with increased levels of both MMA and B12 had a doubled mortality risk compared to those with lower MMA and B12 (p < 0.001).Conclusion MMA accumulation but not serum or dietary vitamin B12 was associated with increased cardiovascular mortality risk among patients with CHD. This paradox may be related to decreased response to vitamin B12.

学科与关键词

关键词
Methylmalonic acidVitamin B12BiomarkerMortalityCoronary Heart Disease
相关
加载中…
  • Cobalamin Intake and Related Biomarkers: Examining Associations With Mortality Risk Among Adults With Type 2 Diabetes in NHANES
    Wang, Shanjie; Wang, Ye; Wan, Xin; Guo, Junchen; Zhang, Yiying; Tian, Maoyi; Fang, Shaohong*; Yu, Bo*Diabetes Care, 2022, 45(2): 276-284.被引 14
  • The Regulation and Characterization of Mitochondrial-Derived Methylmalonic Acid in Mitochondrial Dysfunction and Oxidative Stress: From Basic Research to Clinical Practice
    Liu, Yige; Wang, Shanjie; Zhang, Xiaoyuan; Cai, Hengxuan; Liu, Jinxin; Fang, Shaohong*; Yu, Bo*Oxidative Medicine and Cellular Longevity, 2022, 2022: 7043883.被引 5
  • Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population
    Huang, Yangxi; Lin, Yufeng; Zhai, Xiaobing*; Cheng, Long*Frontiers in Cardiovascular Medicine, 2022, 9: 834150.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Nutrition Journal
发表日期
2023-11-29
卷期
第 22 卷, 第 1 期
页码
63
DOI
10.1186/s12937-023-00900-6
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China

作者

  • G

    Guo, Junchen (第一作者)

    2 · harbin med univ

  • L

    Liu, Xiaoxuan

    2 · harbin med univ

查看全部 10 位作者收起作者
  • W

    Wang, Zeng

    2 · harbin med univ

  • L

    Lu, Rongzhe

    2 · harbin med univ

  • L

    Liu, Yige

    2 · harbin med univ

  • Z

    Zhang, Yiying

    jiamusi univ

  • T

    Tian, Wei

    harbin med univ

  • F

    Fang, Shaohong

    2 · harbin med univ

  • W

    Wang, Shanjie (通讯)

    2 · harbin med univ

  • Y

    Yu, Bo (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417